Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is shown, replacing v3.3.3. No user-facing content or study details appear to be affected.
    Difference
    0.1%
    Check dated 2026-01-14T01:28:28.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section with Oregon as a study site, updating core participation details. Removed the old Oregon Locations label and the HHS Vulnerability Disclosure link; revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:37:48.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2; no study content or navigation changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:37:08.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision number updated from v3.2.0 to v3.3.1 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:33:13.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removed the government funding notice about potential delays and data currency, including references to cc.nih.gov and opm.gov for status.
    Difference
    0.4%
    Check dated 2025-11-17T06:37:14.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Non-significant UI/layout differences are visible between the old and new screenshots, with no changes to core content such as study title, eligibility criteria, interventions, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:16:04.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.